1. Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial. (October 2022) Authors: Salehi, Anahita; Namaei, Parsa; TaghaviZanjani, Fateme; Bagheri, Sayna; Moradi, Kamyar; Khodaei Ardakani, Mohammad-Reza; Akhondzadeh, Shahin Journal: Psychiatry research Issue: Volume 316(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗